Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification
{{output}}
Background & aims: Ferroptosis represents a novel therapeutic approach for HCC. HCC cells rely on glutathione/GPX4 and CoQ10/FSP1 to counteract ferroptosis. The mevalonate pathway enzyme, MVD, generates metabolite IPP to mediate ... ...
